{"author": "Weisberg, E; Griffin, JD ", "adress": "Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave,Mailstop Mayer 540, Boston, MA 02215 USA", "emails": ["ellen_weisberg@dfci.harvard.edu", "james_griffin@dfci.harvard.edu"], "title": "The combination of FLT3 and SYK kinase inhibitors is toxic to leukaemia cells with CBL mutations"}